{
  "docId": "019de070-3b27-7318-9c92-a5817b78bd41",
  "docSlug": "ce86c4a3bf509aea21f24e2159890cb6",
  "documentTitle": "BioNTech | Results Presentation Deck | 28 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 28,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "roadmap",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "The slide uses a Gantt-style visualization for clinical trial phases.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-3b27-7318-9c92-a5817b78bd41/9",
  "deckHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41",
  "deckJsonHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41.json",
  "deckAnchorHref": "/decks/019de070-3b27-7318-9c92-a5817b78bd41#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.11,
        "w": 0.18,
        "x": 0.79,
        "y": 0.43
      },
      "kind": "callout",
      "text": "2. iNeST AACR Phase 1 data update and planned Phase 2 trials in adjuvant NSCLC and CRC",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "276e688a-af73-4c7f-9314-ff86bbcb928f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.18,
        "x": 0.79,
        "y": 0.63
      },
      "kind": "callout",
      "text": "3. Update for anti-PDL1x4-1BB bi-specific antibody expected in 2H 2020",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "631a8ebd-373b-4d1a-ad85-c9eb406ffee4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.18,
        "x": 0.79,
        "y": 0.78
      },
      "kind": "callout",
      "text": "4. Initiation of Phase 1/2 trial for TLR-7 agonist in ES-SCLC",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b9b190fa-bdd9-47e9-8621-0d59746f972a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.18,
        "x": 0.79,
        "y": 0.23
      },
      "kind": "callout",
      "text": "1. BNT111 FixVac Melanoma data in Nature and Regeneron collaboration",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e0d946a4-7c06-4785-9c7f-239062e85d27",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.62,
        "w": 0.22,
        "x": 0.48,
        "y": 0.23
      },
      "kind": "chart",
      "text": "Gantt-style bars representing clinical trial phases for each candidate",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c77d7800-ec1a-49b4-8f43-f85d10034a62",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.76,
        "x": 0.04,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "Footnotes regarding trial details and updates.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7df84da6-71de-4b9d-9a64-c4081a69e90e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.68,
        "w": 0.76,
        "x": 0.04,
        "y": 0.17
      },
      "kind": "table",
      "text": "Pipeline table with columns: Drug class, Platform, Product Candidate, Indication, Phase, Rights/Collaborator",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7bafbe49-9d91-4fde-8e49-46b45c965597",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Expanded clinical stage pipeline to 12 product candidates across 13 trials",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f40a54b-bdc8-4b2f-b537-f2666c5b83c5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "0e54a4dd-c98e-432d-981e-61f922ed5437",
      "evidence": "table/data: Pipeline table with columns: Drug class, Platform, Product Candidate, Indication, Phase, Rights/Collaborator",
      "confidence": 0.5
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "b2f741ff-c55b-4129-bd58-a6949c314ec0",
      "evidence": "The pipeline visualization uses horizontal bars to represent trial phases over time/stage.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 6,
      "beatId": "d225e240-012c-43ec-9ad8-8849e22c98f8",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The presentation highlights the potential for multiple blockbuster opportunities and the need for innovative solutions",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 6,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "558811c9-2680-40b0-851c-c38adb20b5e2",
      "evidence": "The presentation highlights the company's focus on immunotherapy and COVID-19 vaccine development",
      "position": 0,
      "objective": "What are the key areas of focus for BioNTech's pipeline?",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.6,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}